TABLE I.

Experimental Groups and Independent Variables

Group	Number of PVG Recipients	Group Descriptions*	Independent Variables
			Length of Immunosuppression†	AV Bundle	Survival (wk)
1	35	Allotransplant: DA female to PVG male	2 wk	Patent	21
2	28	Allotransplant: DA female to PVG male	2 wk	Ligated	21
3	11	Allograft: DA female to PVG male	2 wk	Patent	21
4	19	Isotransplant: PVG female to PVG male	2 wk	Patent	21

^*DA = Dark Agouti, and PVG = Piebald-Virol-Glaxo.

^†Immunosuppression was accomplished with use of FK-506 (1 mg/kg/day).